Getting Across Tissue Barriers for Precise Delivery of Drugs with Jeff Cleland Ashvattha Therapeutics Empowered Patient Podcast
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations? Pharma’s almanac
What do you consider the biggest challenge that the pharma/biopharma industry currently faces? Pharma’s almanac
Ashvattha’s new self-administered anti-VEGF therapy may address unmet needs for DME Pharmaceutical Technology
Safety data for at-home subcutaneous injection option for treatment of wet AMD, DME Ophthalmology Times
Phase 1 safety data for subcutaneous anti-VEGF candidate for wet AMD, DME presented at ARVO Moderna Retina
Neurologists test novel compound for lung and brain injury in severe COVID-19 patients UT Health Houston News